检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]上海中医药大学附属龙华医院医学伦理委员会,上海200032 [2]上海市中医药发展办公室,上海200002
出 处:《世界科学技术-中医药现代化》2013年第4期697-701,共5页Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基 金:科学技术部国家科技重大专项重大新药创制(2011ZX09302-006-04):中药新药临床评价研究技术平台-中药新药(恶性肿瘤等疾病)临床评价研究技术平台;总课题负责人:田金洲;子课题负责人:王拥军
摘 要:通过分析中西方医学伦理学发展道路的差异,提出我国的医学伦理审查制度虽源于西方,但因为医学伦理思想起源、人种间文化信仰及医学发展和科学模式的不同,该制度应用于我国时不能"生搬硬套",需"和而不同"的理念,并论述建设符合我国国情的伦理审查平台的现状及意义,同时强调对研究者伦理培训的重要性。Through the analysis on different development paths of western and Chinese medical ethics,this article proposed to construct the Chinese medical ethical review system.Although the medical ethical review system was originated in western countries,due to different origins of medical ethical thoughts,different cultures and beliefs among races,as well as different medical and science development models,the application of western medical eth ical review system should not be "mechanically" used in China.The application should follow the idea of "har monization with differences." This article discussed on current status and significance of the construction of an ethical review platform which is suitable to the national conditions of China.It was also emphasized on the im portance of ethics training among researchers.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222